587 related articles for article (PubMed ID: 22283743)
1. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Hsu PI
J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
[TBL] [Abstract][Full Text] [Related]
2. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
3. Management of patients with high gastrointestinal risk on antiplatelet therapy.
Cryer B
Gastroenterol Clin North Am; 2009 Jun; 38(2):289-303. PubMed ID: 19446259
[TBL] [Abstract][Full Text] [Related]
4. Optimal drug therapy after aspirin-induced upper gastrointestinal bleeding.
Struijk M; Postma DF; van Tuyl SA; van de Ree MA
Eur J Intern Med; 2012 Apr; 23(3):227-30. PubMed ID: 22385878
[TBL] [Abstract][Full Text] [Related]
5. Single antiplatelet therapy for patients with previous gastrointestinal bleeds.
Gellatly RM; Ackman ML
Ann Pharmacother; 2008 Jun; 42(6):836-40. PubMed ID: 18413689
[TBL] [Abstract][Full Text] [Related]
6. Strategies to reduce the GI risks of antiplatelet therapy.
Scheiman JM
Rev Cardiovasc Med; 2005; 6 Suppl 4():S23-31. PubMed ID: 17710073
[TBL] [Abstract][Full Text] [Related]
7. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis.
Dai X; Makaryus AN; Makaryus JN; Jauhar R
Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228
[TBL] [Abstract][Full Text] [Related]
8. Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.
Chan FK; Ching JY; Hung LC; Wong VW; Leung VK; Kung NN; Hui AJ; Wu JC; Leung WK; Lee VW; Lee KK; Lee YT; Lau JY; To KF; Chan HL; Chung SC; Sung JJ
N Engl J Med; 2005 Jan; 352(3):238-44. PubMed ID: 15659723
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and gastrointestinal events of three antiplatelet therapies: clopidogrel, clopidogrel plus proton-pump inhibitors, and aspirin plus proton-pump inhibitors in patients with previous gastrointestinal bleeding.
Tsai YW; Wen YW; Huang WF; Chen PF; Kuo KN; Hsiao FY
J Gastroenterol; 2011 Jan; 46(1):39-45. PubMed ID: 20811753
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
Shrestha K; Hughes JD; Lee YP; Parsons R
Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal bleeding after percutaneous coronary intervention.
Tanigawa T; Watanabe T; Nadatani Y; Otani K; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Digestion; 2011; 83(3):153-60. PubMed ID: 21266809
[TBL] [Abstract][Full Text] [Related]
12. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
Luinstra M; Naunton M; Peterson GM; Bereznicki L
J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
[TBL] [Abstract][Full Text] [Related]
13. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
14. Anti-platelet therapy and managing ulcer risk.
Chan FK
J Gastroenterol Hepatol; 2012 Feb; 27(2):195-9. PubMed ID: 22142030
[TBL] [Abstract][Full Text] [Related]
15. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.
Sung JJ; Lau JY; Ching JY; Wu JC; Lee YT; Chiu PW; Leung VK; Wong VW; Chan FK
Ann Intern Med; 2010 Jan; 152(1):1-9. PubMed ID: 19949136
[TBL] [Abstract][Full Text] [Related]
16. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.
Tan VP; Yan BP; Kiernan TJ; Ajani AE
Cardiovasc Revasc Med; 2009; 10(1):36-44. PubMed ID: 19159853
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal bleeding in the setting of anticoagulation and antiplatelet therapy.
Barada K; Abdul-Baki H; El Hajj II; Hashash JG; Green PH
J Clin Gastroenterol; 2009 Jan; 43(1):5-12. PubMed ID: 18607297
[TBL] [Abstract][Full Text] [Related]
18. Statements of the Malaysian Society of Gastroenterology & Hepatology and the National Heart Association of Malaysia task force 2012 working party on the use of antiplatelet therapy and proton pump inhibitors in the prevention of gastrointestinal bleeding.
Tan HJ; Mahadeva S; Menon J; Ng WK; Zainal Abidin I; Chan FK; Goh KL; ;
J Dig Dis; 2013 Jan; 14(1):1-10. PubMed ID: 23134105
[TBL] [Abstract][Full Text] [Related]
19. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
[TBL] [Abstract][Full Text] [Related]
20. Combining aspirin and proton pump inhibitors: for whom the warning bell tolls?
Würtz M; Grove EL
Expert Opin Drug Metab Toxicol; 2012 Sep; 8(9):1051-5. PubMed ID: 22834712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
